Benjamin Hickey, EVP, Chief Commercial Officer at Mirati Therapeutics, Inc. (MRTX), sold 2,563 shares at $59.02 ($151K) on 2024-01-16, disclosed to the SEC on 2024-01-18.
Seasonal sale ($151k) by EVP, Chief Commercial Officer — this insider has traded MRTX in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.02 | 631 | $37K | 24.6% |
| 2 | $59.02 | 966 | $57K | 37.7% |
| 3 | $59.02 | 966 | $57K | 37.7% |
| Total | $59.02 avg | 2,563 | $151K | 100% |
| Filing → |
| MRTX | SELL | 2023-12-14 | $252K | — | Filing → |
| MRTX | SELL | 2023-01-19 | $66K | — | Filing → |
| MRTX | SELL | 2023-01-10 | $189K | — | Filing → |